Related Experiment Video
Updated: May 22, 2026
A Multiplexed Luciferase-based Screening Platform for Interrogating Cancer-associated Signal Transduction in Cultured Cells
Published on: July 3, 2013
Integrative multi-omics identification and functional validation of potential targets linking
1The Affiliated Lihuili Hospital of Ningbo University, Health Science Center, Ningbo University, Ningbo, Zhejiang, China.
Introduction:
Colorectal cancer (CRC) remains a major global health burden, highlighting the need for novel molecular targets for therapy and prognosis. This study integrates multi-omics data with functional assays to explore metabolite-mediated mechanisms in CRC risk.
Methods:
We performed genetic causal inference and colocalization analyses using genome-wide association data to assess causality between 233 metabolites and CRC. A total of 731 immune traits were investigated as potential mediators. Metabolite-associated CpG sites were identified via epigenome-wide association studies (EWAS), and their methylation QTLs (mQTLs) were linked to target genes through interaction eQTL analysis via FUMAGWAS. Expression, prognosis, immune infiltration, and regulatory associations of target genes were analyzed using TCGA datasets. Functional assays were conducted in NCM460 and CRC cell lines (HCT116, SW480, CACO2). CRC xenograft mice were used to monitor tumor growth in vivo.
Results:
A higher omega-3 fatty acid ratio (FAw3byFA, OR = 1.22, P = 2.51×10-7) was associated with increased CRC risk, with partial mediation (10%) via Effector Memory CD4+ T cells. Colocalization (PP.H4 ≈ 0.97) suggested shared genetic loci. Genetically predicted omega-3-associated CpG sites, cg05181941, cg06817802, and cg22456785, were linked to CRC risk. These sites-derived 428 mQTLs interact with eQTL genes, highlighting SLC6A19 as a potential target, expressed in CD4+ T cells , colon tissue and CRC epithelial cells. SLC6A19 was downregulated in TCGA-COAD, -READ, and -COADREAD and confirmed by immunoblotting, correlating with poor survival and CD4+ T cell infiltration. CCK-8, wound healing, and Transwell assays showed that SLC6A19 overexpression suppressed CRC cell proliferation, migration, and invasion. In vivo, SLC6A19 overexpression significantly reduced CRC xenograft tumor growth.
Conclusions:
Omega-3-related methylation-intersecting SLC6A19 potentially mediates omega-3-CD4+ T cells-driven CRC risk, suggesting a candidate inhibitory target.
More Related Videos
07:47Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies
Published on: September 15, 2023
03:08Using Human Differentially Expressed Gene Lists to Perform Downstream Pathway Enrichment Analysis and Target Prioritization
Published on: October 3, 2025
